Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F2C64
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,186
Award facts
- Contract value 100% obligated
- $69,186.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $69,186.22 delivery order to AmerisourceBergen Drug Corp on February 17, 2026, for Cosentyx (secukinumab) 300 mg pen 2 ml pharmaceutical supply.
Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 18, 2026, under firm fixed-price terms. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26F2C64?
SPE2DR26F2C64 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 17, 2026.
How much is contract SPE2DR26F2C64 worth?
The government has obligated $69,186 on SPE2DR26F2C64.
Is contract SPE2DR26F2C64 an order under another contract?
Yes. SPE2DR26F2C64 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F2C64 competed?
The extent of competition for SPE2DR26F2C64 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award